+91 7682 015 542       info@gexinonline.com

  • Account
    • Sign In
      • Author
      • Editor
      • Reviewer
    • Sign Up
      • Author
logo
  • Home
  • Open Access
  • About Us
    • About Us
    • Our Team
  • Journal
  • Submission
    • Submit Manuscript
    • Instructions to Authors
    • Review Process
    • Join As Reviewers
    • Our Reviewers
  • Policies & Ethics
    • Open Access Policy
    • Editorial Policy
    • Conflict of Interest
    • Publication Ethics and Malpractice Statement
    • Plagiarism Policy
    • Review Policy
    • Correction, Retraction, Withdrawal Policies
    • Digital Preservation Policy
    • Waiver Policy
    • Complaints Policy
    • Advertising Policy
    • Data Sharing Policy
    • Policy on Statement of Informed Consent
    • Policy on Ethics of Human and Animal Experimentation
  • Contact Us
  • About the Journal
  • Editorial Board
  • Review Process
  • Author Guidelines
  • Article Processing Charges
  • Special Issues
  • Current Issue
  • Past Issue
Journal of CAM Research Progress
Full-Text HTML   Full-Text PDF  

Journal of CAM Research Progress Volume 2 (2023), Article ID: JCRP-113

https://doi.org/10.33790/jcrp1100113

Commentary Article

Advancement of Network Pharmacology in Multi-targeted Therapeutic Evaluation of Medicinal Plants

Gaurav Gautam

Senior Researcher, Department of Pharmacognosy and Phytochemistry, IIMT College of Medical Sciences, IIMT University, ‘O’ Pocket Ganga Nagar-250001, Meerut, Uttar Pradesh, India.

Corresponding Author: Gaurav Gautam, Senior Researcher, Department of Pharmacognosy and Phytochemistry, IIMT College of Medical Sciences, IIMT University, ‘O’ Pocket Ganga Nagar-250001, Meerut, Uttar Pradesh, India.

Received date: 22nd October, 2023

Accepted date: 03rd November, 2023

Published date: 07th November, 2023

Citation: Gautam, G., (2023). Advancement of Network Pharmacology in Multi-targeted Therapeutic Evaluation of Medicinal Plants. J CAM Res Progress, 2(1): 113.

Copyright: ©2023, This is an open-access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Abstract

In recent years, network pharmacology has emerged as a powerful approach for understanding the complex interactions between various bioactive components of medicinal plants and their targets within biological systems [1,2]. This approach plays a pivotal role in evaluating the multi-targeted therapeutic potential of medicinal plants, making it a promising tool for drug discovery and development. The integration of traditional knowledge with modern analytical techniques and computational methods has enabled the comprehensive exploration of the pharmacological properties of medicinal plants [3-6]. Medicinal plants have been an essential part of traditional medicine systems worldwide for centuries. These plants contain a wide array of bioactive compounds, such as alkaloids, flavonoids, terpenoids, and polyphenols, which exert therapeutic effects through interactions with specific molecular targets [7,8]. However, elucidating the intricate relationships between these compounds and their targets has proven challenging [2].

Network pharmacology offers a holistic approach to this problem by incorporating techniques from network science, systems biology, and chemoinformatics. It allows researchers to construct complex interaction networks that connect bioactive compounds to their target proteins. By analyzing these networks, it becomes possible to predict how different compounds from medicinal plants may exert their therapeutic effects on various disease pathways [9,10]. One of the major advantages of network pharmacology is its capacity to explore the potential multitargeted effects of medicinal plants. Unlike single target drugs, many diseases involve a network of interconnected molecular pathways. Medicinal plants, with their multiple bioactive components, can influence multiple points within these networks, providing a holistic approach to treatment [3,7,11,12]. In a recent study conducted on network pharmacological based exploration of therapeutic targets of Boerhaavia diffusa and Tinospora cordifolia herbal combination in chronic kidney disease, it has been reported that the major constituents of these plants such as quercetin, ferulic acid, gallic acid, ameliorates the different pathophysiological targets in treatment of kidney disease [4]. Ekbbal et al reported that effect of rosmarinic acid in regulation of Proto-Oncogene c-Fos, Interleukin 2 and Poly (ADP-Ribose) Glycohydrolase, lymphocyte-specific protein tyrosine kinase (LCK), an inhibitor of nuclear factor kappa B kinase subunit beta (IKBKB), C-C motif chemokine receptor 3 (CCR3), Protein C Receptor (PROCR), etc Genomic Expression in attenuation of diabetes and associated complications [13]. Gautam (2022) reported traditional therapeutic claim of Momordica Charantia in alleviation of diabetic nephropathy using neptrok pharmacological approaches. The results showed that polyphenols present in Momordica Charantia play a significant role in the etiology and treatment of diabetic neuropathy by regulating numerous genomes includes AKTs, CASPs, MAPKs, ILs, NOs, etc [6].

In a study published in Biomedicine journal, multi-mechanistic and therapeutic targets were determined of a India’s polyherbal formulation “NEERI KFT” using network pharmacological approaches and reported that gallic acid, quercetin, ferulic acid, etc exhibits a significant role in alleviation of nephrotoxicity induce by cisplatin [3,14]. Tinospora cordifolia is one of the most india’s famous medicinal plants used for several therapeutic effect. Gaurav et al reported that it plays a significant effect in alleviation of kidney disease via regulating several pathophysiological targets involved in kidney disease. Furthermore, it was reported that five fatty acids were identified by network pharmacological interaction analysis as having a significant impact on genes including AGTR1, ATG, RELA, NOS3, NOS2, REN, INS, IL6, TNF, MAPK1, and CASP3. These genes may be able to regulate a number of pathophysiological conditions, including insulin resistance, hypertension, oxidative and inflammatory stress, and electrolyte homeostasis, thus supporting normal kidney function [5].

Additionally, network pharmacology helps identify critical hubs or key target proteins within the interaction network [13,15,16]. These hubs often play essential roles in disease development and progression. By targeting these hubs, researchers can develop more effective therapeutic strategies and prioritize compounds with the highest potential for clinical success. Furthermore, network pharmacology assists in the identification of drug-repurposing opportunities. Many medicinal plants have been traditionally used for specific conditions, but network pharmacology may reveal their potential efficacy in treating other diseases. This approach minimizes the time and cost required for developing new drugs by repurposing existing natural remedies [13,17,18]. It has been reported that [19].

In conclusion, the advancement of network pharmacology has provided a robust platform for the multi-targeted therapeutic evaluation of medicinal plants. It combines the knowledge of traditional medicine with modern techniques to uncover the intricate interactions between bioactive compounds and their molecular targets. This approach enhances our understanding of the therapeutic potential of medicinal plants, making them valuable sources of new drug candidates and treatment strategies. As we continue to unveil the full potential of network pharmacology, we can expect more effective and holistic approaches to addressing various health challenges.

Acknowledgement

Author would like to thank Department of Pharmacognosy and Phytochemistry, IIMT College of Medical Sciences, IIMT University, ‘O’ Pocket Ganga Nagar-250001, Meerut, Uttar Pradesh, India for providing assistance in this study.

Conflict of interest:

Author declare no conflict of interest.

References

  1. M. Misra, B. Chauhan, R. Ekbbal, S. Yadav, N. kaur Gaurav, Y. Yasheshwar, (2023). Exploring antihypertensive effect of rutin through system based computational analysis, Ann. Phytomedicine An Int. J. 12. 1–7. https://doi.org/10.54085/ ap.2023.12.1.69.View

  2. S. Salar, Gaurav, P. Sharma, (2023). Quality Control and Multi-targeted Therapeutic Approach of Nyctanthes arbor-tristris for Management of Hepatic Disease and Associated Complications, Pharmacogn. Mag. https://doi. org/10.1177/09731296231189619.View

  3. Gaurav, I. Sharma, M.U. Khan, S. Zahiruddin, P. Basist, S. Ahmad, (2023). Multi-Mechanistic and Therapeutic Exploration of Nephroprotective Effect of Traditional Ayurvedic Polyherbal Formulation Using In Silico, In Vitro and In Vivo Approaches, Biomedicines. 11. https://doi.org/10.3390/ biomedicines11010168View

  4. Gaurav, M.U. Khan, P. Basist, S. Zahiruddin, M. Ibrahim, R. Parveen, A. Krishnan, S. Ahmad, (2022). Nephroprotective potential of Boerhaavia diffusa and Tinospora cordifolia herbal combination against diclofenac induced nephrotoxicity, South African J. Bot. 000. https://doi.org/10.1016/j.sajb.2022.01.038View

  5. Gaurav, GC–MS (2022). metabolomics and network pharmacology-based investigation of molecular mechanism of identified metabolites from Tinospora cordifolia (Willd.) miers for the treatment of kidney diseases, Pharmacogn. Mag. 18. 548–558. https://doi.org/10.4103/pm.pm_582_21View

  6. G. Gautam, (2022). Network Pharmacology-Based Validation of Traditional Therapeutic Claim of Momordica Charantiain Alleviating Diabetic Nephropathy, J. CAM Res. Prog. 1,1–10.View

  7. M.U. Khan, P. Basist, Gaurav, S. Zahiruddin, N.R. Penumallu, S. Ahmad, (2024). Ameliorative effect of traditional polyherbal formulation on TNF-α, IL-1β and Caspase-3 expression in kidneys of wistar rats against sodium fluoride induced oxidative stress, J. Ethnopharmacol. https://doi.org/10.1016/j. jep.2023.116900.View

  8. M.U. Khan, Gaurav, S. Zahiruddin, P. Basist, A. Krishnan, R. Parveen, S. Ahmad, (2022). Nephroprotective potential of Sharbat-e-Bazoori Motadil (sugar-free) in HEK-293 cells and Wistar rats against cisplatin induced nephrotoxicity, J. King Saud Univ. - Sci. 34. 101839. https://doi.org/10.1016/j. jksus.2022.101839.View

  9. G. Gautam, R. Parveen, S. Ahmad, (2023). LC-MS-based Metabolomics of Medicinal Plants, in: Omi. Stud. Med. Plants, https://doi.org/10.1201/9781003179139-9.View

  10. S. Ali, R. Ekbbal, S. Salar, S.A. Ali, A.K. Jaiswal, M. Singh, D.K. Yadav, S. Kumar, (2023). Quality Standards and Pharmacological Interventions of Natural Oils : Current Scenario and Future Perspectives. https://doi.org/10.1021/ acsomega.3c05241View

  11. S. Ahmad, S. Zahiruddin, B. Parveen, P. Basist, A. Parveen, Gaurav, R. Parveen, M. Ahmad, (2021). Indian Medicinal Plants and Formulations and Their Potential Against COVID-19 Preclinical and Clinical Research, Front. Pharmacol. https:// doi.org/10.3389/fphar.2020.578970.View

  12. S. Zahiruddin, P. Basist, A. Parveen, R. Parveen, W. Khan, Gaurav, S. Ahmad, (2020). Ashwagandha in brain disorders: A review of recent developments, J. Ethnopharmacol. https://doi. org/10.1016/j.jep.2020.112876.View

  13. R. Ekbbal, M.S. Akhtar, W.M. Al-shaqha, S. Kumar, A.K. Jaiswal, M. Aggarwal, D.K. Yadav, M. Islam, (2023). Regulation of Interleukin 2 , Proto-Oncogene c-Fos and Poly ( ADP Ribose) Glycohydrolase Genomic Expression by Rosmarinic Acid in Attenuation of Diabetes and Associated Complications, 37. 3321–3331.View

  14. G. Gautam, B. Parveen, M. Umar Khan, I. Sharma, A. Kumar Sharma, R. Parveen, S. Ahmad, (2021). A systematic review on nephron protective AYUSH drugs as constituents of NEERI KFT (A traditional Indian polyherbal formulation) for the management of chronic kidney disease, Saudi J. Biol. Sci. https://doi.org/10.1016/J.SJBS.2021.07.008.View

  15. Gaurav, S. Zahiruddin, B. Parveen, M. Ibrahim, I. Sharma, S. Sharma, A.K. Sharma, R. Parveen, S. Ahmad, (2020). TLC-MS bioautography-based identification of free-radical scavenging, α-amylase, and α-glucosidase inhibitor compounds of antidiabetic tablet BGR-34, ACS Omega. https://doi. org/10.1021/acsomega.0c02995.View

  16. Gaurav, N. Anwar, S. Zahiruddin, S. Ahmad, (2023). TLC bioautography-MS-based Identification of Antioxidant, α-Amylase and α-Glucosidase Inhibitory Compounds in a Polyherbal Formulation “Sugreen-120,” Pharmacogn. Mag. https://doi.org/10.1177/09731296221145064.View

  17. M.A. Ansari, A. Iqubal, R. Ekbbal, S.E. Haque, (2019). Effects of nimodipine, vinpocetine and their combination on isoproterenol-induced myocardial infarction in rats, Biomed. Pharmacother. https://doi.org/10.1016/j.biopha.2018.10.199.View

  18. R. Ekbbal, A. Iqubal, M. Ansari, S. Ahmad, S. Haque, (2022). Evaluation of cardioprotective potential of isolated swerchirin against the isoproterenol-induced cardiotoxicity in wistar albino rats, Pharmacogn. Mag. https://doi.org/10.4103/ pm.pm_500_20.View

  19. J. Sharma, S. Gairola, Y.P. Sharma, R.D. (2014). Gaur, Ethnomedicinal plants used to treat skin diseases by Tharu community of district Udham Singh Nagar, Uttarakhand, India, J. Ethnopharmacol. https://doi.org/10.1016/j.jep.2014.10.004.View

LICENSE

This work is licensed under a Creative Commons Attribution 4.0 International License.

Quick Links

  • Open Access
  • About Us
  • Journal
  • Submit Manuscript
  • Copyright & Licensing Policy

Contact Us

  • Plot No. - 814/1775, Jayar Sasan, Bhubaneswar, Odisha, India, Pin - 752101
  • +91 7682 015 542
  • info@gexinonline.com
MEMBER OF
JOURNAL ARCHIVED IN

© Gexin Publications.

All Rights Reserved.